The Maxon Group achieved a new sales record in the 2019 financial year, despite a noticeable global economic slowdown. "In 2019, we once again invested a lot of time and money to make the Maxon Group fit for the future," says Karl-Walter Braun, main shareholder. "Thanks to our healthy financial situation, we were able to make all investments from our own resources. We are constantly adapting the Group's organization to the new size of the company in order to be able to handle future growth," says Braun.

Maxon has been investing a high single-digit percentage of its turnover in research and development for years. In 2019, investments amounted to over CHF 38 million "Around 340 R&D employees ensure that we are constantly developing and innovating. We have long since ceased to be a pure electric motor manufacturer, but are continuously developing into a provider of complete mechatronic drive systems consisting of precision electric motors, high-performance gearboxes and intelligent control electronics," says Eugen Elmiger, Delegate of the Board of Directors and CEO. The company benefits from the fact that "we can design and produce gearboxes, electric motors and control electronics ourselves within the Group," says Elmiger. This has enabled Maxon to act flexibly and quickly "to develop, manufacture and supply motors for ventilators and linear drives for laboratory automation for evaluating coronavirus tests," says Elmiger.

Globally active and broadly positioned

The industries with the highest turnover are medical technology, industrial automation and robotics. Other major markets are measurement and testing technology, aerospace and the automotive industry. Maxon is also an important partner in international space programs.

The maxon Group is globally active and broadly positioned in the markets and has a solid foundation to continue to hold its own as the global market leader in the future. Incoming orders for the second half of 2020, except for medical technology products, are still weak, says Eugen Elmiger. "We are therefore currently expecting a reduction in sales of around ten percent compared to the record year of 2019."